Comparative molecular field analysis and molecular dynamics studies of α/β hydrolase domain containing 6 (ABHD6) inhibitors

Verfasser / Beitragende:
[Agnieszka Kaczor, Katarzyna Targowska-Duda, Jayendra Patel, Tuomo Laitinen, Teija Parkkari, Yahaya Adams, Tapio Nevalainen, Antti Poso]
Ort, Verlag, Jahr:
2015
Enthalten in:
Journal of Molecular Modeling, 21/10(2015-10-01), 1-16
Format:
Artikel (online)
ID: 605512124
LEADER caa a22 4500
001 605512124
003 CHVBK
005 20210128100654.0
007 cr unu---uuuuu
008 210128e20151001xx s 000 0 eng
024 7 0 |a 10.1007/s00894-015-2789-8  |2 doi 
035 |a (NATIONALLICENCE)springer-10.1007/s00894-015-2789-8 
245 0 0 |a Comparative molecular field analysis and molecular dynamics studies of α/β hydrolase domain containing 6 (ABHD6) inhibitors  |h [Elektronische Daten]  |c [Agnieszka Kaczor, Katarzyna Targowska-Duda, Jayendra Patel, Tuomo Laitinen, Teija Parkkari, Yahaya Adams, Tapio Nevalainen, Antti Poso] 
520 3 |a The endocannabinoid system remains an attractive molecular target for pharmacological intervention due to its roles in the central nervous system in learning, thinking, emotional function, regulation of food intake or pain sensation, as well as in the peripheral nervous system, where it modulates the action of cardiovascular, immune, metabolic or reproductive function. α/β hydrolase domain containing 6 (ABHD6)—an enzyme forming part of the endocannabinoid system—is a newly discovered post-genomic protein acting as a 2-AG (2-arachidonoylglycerol) serine hydrolase. We have recently reported a series of 1,2,5-thiadiazole carbamates as potent and selective ABHD6 inhibitors. Here, we present comparative molecular field analysis (CoMFA) and molecular dynamics studies of these compounds. First, we performed a homology modeling study of ABHD6 based on the assumption that the catalytic triad of ABHD6 comprises Ser148-His306-Asp 278 and the oxyanion hole is formed by Met149 and Phe80. A total of 42 compounds was docked to the homology model using the Glide module from the Schrödinger suite of software and the selected docking poses were used for CoMFA alignment. A model with the following statistics was obtained: R 2=0.98, Q 2=0.55. In order to study the molecular interactions of the inhibitors with ABHD6 in detail, molecular dynamics was performed with the Desmond program. It was found that, during the simulations, the hydrogen bond between the inhibitor carbonyl group and the main chain of Phe80 is weakened, whereas a new hydrogen bond with the side chain of Ser148 is formed, facilitating the possible formation of a covalent bond. Graphical Abstract Left-right: Docking pose of 1 in the binding pocket of α/β hydrolase domain containing 6 (ABHD6) selected for molecular alignment; CoMFA steric and electrostatic contour fields; changes in potential energy of the complex during simulations for the complex of 6 and ABHD6 
540 |a The Author(s), 2015 
690 7 |a ABHD6  |2 nationallicence 
690 7 |a ABHD6 inhibitors  |2 nationallicence 
690 7 |a CoMFA  |2 nationallicence 
690 7 |a The endocannabinoid system  |2 nationallicence 
690 7 |a Homology modeling  |2 nationallicence 
690 7 |a Molecular docking  |2 nationallicence 
690 7 |a Molecular dynamics  |2 nationallicence 
690 7 |a 2-AG : 2-Arachidonoylglycerol  |2 nationallicence 
690 7 |a ABHD6 : α/β Hydrolase domain containing 6  |2 nationallicence 
690 7 |a ABHD12 : α/β Hydrolase domain containing 12  |2 nationallicence 
690 7 |a ANN : Artificial neural network  |2 nationallicence 
690 7 |a CB1 : Cannabinoid receptor 1  |2 nationallicence 
690 7 |a CB2 : Cannabinoid receptor 2  |2 nationallicence 
690 7 |a CoMFA : Comparative molecular field analysis  |2 nationallicence 
690 7 |a CoMSIA : Comparative molecular similarity index analysis  |2 nationallicence 
690 7 |a DSE : Depolarization-induced suppression of excitation  |2 nationallicence 
690 7 |a DSI : Depolarization-induced suppression of inhibition  |2 nationallicence 
690 7 |a ECS : Endocannabinoid signaling system  |2 nationallicence 
690 7 |a G/PLS : Genetic partial least squares  |2 nationallicence 
690 7 |a LOO : Leave-one-out  |2 nationallicence 
690 7 |a MD : Molecular dynamics  |2 nationallicence 
690 7 |a MGL : Monoacylglycerol lipase  |2 nationallicence 
690 7 |a ONC : Optimum number of components  |2 nationallicence 
690 7 |a PLS : Partial least squares  |2 nationallicence 
690 7 |a QSAR : Quantitative structure-activity relationship  |2 nationallicence 
690 7 |a SEE : Standard error of estimation  |2 nationallicence 
700 1 |a Kaczor  |D Agnieszka  |u Department of Synthesis and Chemical Technology of Pharmaceutical Substances with Molecular Modeling Laboratory, Faculty of Pharmacy with Division of Medical Analytics, Medical University of Lublin, 4a Chodźki St., 20059, Lublin, Poland  |4 aut 
700 1 |a Targowska-Duda  |D Katarzyna  |u Department of Biopharmacy, Faculty of Pharmacy with Division of Medical Analytics, Medical University of Lublin, 4a Chodźki St., 20059, Lublin, Poland  |4 aut 
700 1 |a Patel  |D Jayendra  |u School of Pharmacy, University of Eastern Finland, Yliopistonranta 1, PO Box 1627, 70211, Kuopio, Finland  |4 aut 
700 1 |a Laitinen  |D Tuomo  |u School of Pharmacy, University of Eastern Finland, Yliopistonranta 1, PO Box 1627, 70211, Kuopio, Finland  |4 aut 
700 1 |a Parkkari  |D Teija  |u School of Pharmacy, University of Eastern Finland, Yliopistonranta 1, PO Box 1627, 70211, Kuopio, Finland  |4 aut 
700 1 |a Adams  |D Yahaya  |u School of Pharmacy, University of Eastern Finland, Yliopistonranta 1, PO Box 1627, 70211, Kuopio, Finland  |4 aut 
700 1 |a Nevalainen  |D Tapio  |u School of Pharmacy, University of Eastern Finland, Yliopistonranta 1, PO Box 1627, 70211, Kuopio, Finland  |4 aut 
700 1 |a Poso  |D Antti  |u School of Pharmacy, University of Eastern Finland, Yliopistonranta 1, PO Box 1627, 70211, Kuopio, Finland  |4 aut 
773 0 |t Journal of Molecular Modeling  |d Springer Berlin Heidelberg  |g 21/10(2015-10-01), 1-16  |x 1610-2940  |q 21:10<1  |1 2015  |2 21  |o 894 
856 4 0 |u https://doi.org/10.1007/s00894-015-2789-8  |q text/html  |z Onlinezugriff via DOI 
898 |a BK010053  |b XK010053  |c XK010000 
900 7 |a Metadata rights reserved  |b Springer special CC-BY-NC licence  |2 nationallicence 
908 |D 1  |a research-article  |2 jats 
949 |B NATIONALLICENCE  |F NATIONALLICENCE  |b NL-springer 
950 |B NATIONALLICENCE  |P 856  |E 40  |u https://doi.org/10.1007/s00894-015-2789-8  |q text/html  |z Onlinezugriff via DOI 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Kaczor  |D Agnieszka  |u Department of Synthesis and Chemical Technology of Pharmaceutical Substances with Molecular Modeling Laboratory, Faculty of Pharmacy with Division of Medical Analytics, Medical University of Lublin, 4a Chodźki St., 20059, Lublin, Poland  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Targowska-Duda  |D Katarzyna  |u Department of Biopharmacy, Faculty of Pharmacy with Division of Medical Analytics, Medical University of Lublin, 4a Chodźki St., 20059, Lublin, Poland  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Patel  |D Jayendra  |u School of Pharmacy, University of Eastern Finland, Yliopistonranta 1, PO Box 1627, 70211, Kuopio, Finland  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Laitinen  |D Tuomo  |u School of Pharmacy, University of Eastern Finland, Yliopistonranta 1, PO Box 1627, 70211, Kuopio, Finland  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Parkkari  |D Teija  |u School of Pharmacy, University of Eastern Finland, Yliopistonranta 1, PO Box 1627, 70211, Kuopio, Finland  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Adams  |D Yahaya  |u School of Pharmacy, University of Eastern Finland, Yliopistonranta 1, PO Box 1627, 70211, Kuopio, Finland  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Nevalainen  |D Tapio  |u School of Pharmacy, University of Eastern Finland, Yliopistonranta 1, PO Box 1627, 70211, Kuopio, Finland  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Poso  |D Antti  |u School of Pharmacy, University of Eastern Finland, Yliopistonranta 1, PO Box 1627, 70211, Kuopio, Finland  |4 aut 
950 |B NATIONALLICENCE  |P 773  |E 0-  |t Journal of Molecular Modeling  |d Springer Berlin Heidelberg  |g 21/10(2015-10-01), 1-16  |x 1610-2940  |q 21:10<1  |1 2015  |2 21  |o 894